Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Dexcom (DXCM) Gets a Buy from Wells Fargo
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...
GlobalData on MSN13h
Omnipod 5 improves glycaemic levels in people transitioning from daily injections
Individuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...
Top Stock Movers Now: Darden Restaurants, Jabil, Accenture, and More
U.S. equities were up again at midday after Federal Reserve Chair Jerome Powell downplayed worries about a U.S. economic ...
Harbor Police Department HQ on San Diego Bay slated for redevelopment
The Port of San Diego wants to demolish the 77-year-old police headquarters on East Harbor Island and erect a new facility at ...
Zacks Investment Research on MSN11h
PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5
Insulet Corporation PODD announced favorable RADIANT trial clinical data for its Omnipod 5 at the 18th International Conference on Advanced Technologies and Treatments for Diabetes (“ATTD”). Omnipod 5 ...
Nick Jonas gets candid in exclusive essay: 'I stand at a pivotal juncture'
Nick Jonas writes about his diabetes journey, "The Last Five Years," fatherhood and more in this exclusive essay.